H Kawachi Selected Research

Puromycin Aminonucleoside

4/2008	Decreased tyrosine phosphorylation of nephrin in rat and human nephrosis.
3/2008	Nephrin mediates actin reorganization via phosphoinositide 3-kinase in podocytes.
8/2007	Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.
12/2006	Expression of allograft inflammatory factor-1 in kidneys: A novel molecular component of podocyte.
12/2001	Podocyte injuries exacerbate mesangial proliferative glomerulonephritis.
5/2000	Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Kawachi Research Topics

Disease

12	Glomerulonephritis 03/2011 - 01/2000
9	Proteinuria 08/2007 - 05/2000
5	Nephritis 12/2006 - 08/2000
4	Nephrosis 04/2008 - 06/2000
3	Albuminuria 01/2004 - 07/2001
2	Neoplasms (Cancer) 07/2010 - 03/2001
2	Kidney Diseases (Kidney Disease) 08/2007 - 03/2006
2	Nephrotic Syndrome (Syndrome, Nephrotic) 08/2007 - 05/2000
2	Body Weight (Weight, Body) 12/2001 - 11/2000
2	Hypertension (High Blood Pressure) 07/2001 - 11/2000
1	Abdominal Aortic Aneurysm 02/2013
1	MYH9-Related Disorders 03/2011
1	Lymphatic Metastasis 07/2010
1	Esophageal Squamous Cell Carcinoma 07/2010
1	Disease Progression 03/2006
1	Ureteral Obstruction 03/2006
1	Fibrosis (Cirrhosis) 11/2001
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2001
1	Membranous Glomerulonephritis (Membranous Nephropathy) 02/2001
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2000
1	Hypertensive Nephropathy 11/2000
1	Colitis 10/2000
1	Thrombosis (Thrombus) 01/2000
1	Pain (Aches) 01/2000

Drug/Important Bio-Agent (IBA)

6	Puromycin AminonucleosideIBA 04/2008 - 05/2000
5	nephrinIBA 04/2008 - 05/2000
5	Messenger RNA (mRNA)IBA 12/2006 - 08/2000
5	Monoclonal AntibodiesIBA 03/2006 - 07/2000
4	Proteins (Proteins, Gene)FDA Link 12/2006 - 11/2000
4	anti-Thy antibodyIBA 03/2006 - 08/2000
3	Transforming Growth Factor beta (TGF-beta)IBA 02/2001 - 08/2000
2	Cadherins (E-Cadherin)IBA 07/2010 - 03/2001
2	Tyrosine (L-Tyrosine)FDA Link 04/2008 - 03/2008
2	Interleukin-10 (Interleukin 10)IBA 08/2003 - 10/2000
1	Immunoglobulin G (IgG)IBA 03/2011
1	Antigen-Antibody Complex (Immune Complex)IBA 03/2011
1	Claudin-5IBA 07/2010
1	beta CateninIBA 07/2010
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 07/2010
1	Erythropoietin FDA Link 08/2007
1	PuromycinIBA 08/2007
1	antiglomerular basement membrane antibodyIBA 12/2006
1	DNA (Deoxyribonucleic Acid)IBA 12/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2006
1	thymosin beta(10)IBA 03/2006
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 06/2005
1	pimagedine (aminoguanidine)IBA 01/2004
1	Perindopril FDA LinkGeneric 01/2004
1	Collagen Type I (Type I Collagen)IBA 12/2001
1	Isotretinoin (Accutane)FDA LinkGeneric 12/2001
1	RetinoidsIBA 12/2001
1	AcidsIBA 12/2001
1	Transforming Growth Factor-beta Type II ReceptorIBA 11/2001
1	Angiotensin IIIBA 07/2001
1	Irbesartan FDA LinkGeneric 07/2001
1	AlbuminsIBA 02/2001
1	Complement System Proteins (Complement)IBA 02/2001
1	CaveolinsIBA 02/2001
1	cobra venom factorIBA 02/2001
1	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 02/2001
1	GoldIBA 02/2001
1	Platelet-Derived Growth FactorIBA 02/2001
1	EpitopesIBA 02/2001
1	Caveolin 1IBA 02/2001
1	Hydralazine (Apresoline)FDA LinkGeneric 11/2000
1	CreatinineIBA 11/2000
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 11/2000
1	benidipineIBA 11/2000
1	CytokinesIBA 10/2000
1	InterferonsIBA 10/2000
1	InterleukinsIBA 10/2000
1	AnticoagulantsIBA 01/2000
1	Antithrombin IIIIBA 01/2000

Therapy/Procedure

2	Therapeutics 01/2004 - 01/2000
1	Endovascular Aneurysm Repair 02/2013
1	Intravenous Injections 03/2006
1	Injections 12/2001
1	Nephrectomy 06/2000